1. Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy
    Reginald Anunobi et al, 2018, Journal of Surgical Research CrossRef
  2. The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer
    Heikki Huhta et al, 2016, Journal of Histochemistry & Cytochemistry CrossRef
  3. TLR3 expression status predicts prognosis in patients with advanced thoracic esophageal squamous cell carcinoma after esophagectomy
    Yusuke Sato et al, 2018, The American Journal of Surgery CrossRef
  4. The Association Between Gut Microbiota, Toll-Like Receptors, and Colorectal Cancer
    Yongkun Fang et al, 2022, Clinical Medicine Insights: Oncology CrossRef
  5. Epistatic effect of TLR3 and cGAS‐STING‐IKKε‐TBK1‐IFN signaling variants on colorectal cancer risk
    Calogerina Catalano et al, 2020, Cancer Medicine CrossRef
  6. TLR3 Is a Death Receptor Target in Cancer Therapy
    Yann Estornes et al, 2017, TRAIL, Fas Ligand, TNF and TLR3 in Cancer CrossRef
  7. Toll-like receptor 9 expression in the natural history of Barrett mucosa
    Heikki Huhta et al, 2015, Virchows Archiv CrossRef
  8. Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells
    Wai Hoe Lau et al, 2017, Oncotarget CrossRef
  9. Folic acid modulates cancer‐associated micro RNAs and inflammatory mediators in neoplastic and non‐neoplastic colonic cells in a different way
    Birgit Niemann et al, 2017, Molecular Nutrition & Food Research CrossRef
  10. Role of TLR9 in Oncogenic Virus-Produced Cancer
    Cecilia Martínez-Campos et al, 2017, Viral Immunology CrossRef
  11. Dietary nano-selenium improves health of liver and intestine of grass carp Ctenopharyngodon idella after overwintering
    Limin Ye et al, 2023, Animal Feed Science and Technology CrossRef
  12. Circulating cell-free mitochondrial DNA as the probable inducer of early endothelial dysfunction in the prediabetic patient
    Noé Alvarado-Vásquez, 2015, Experimental Gerontology CrossRef
  13. Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention
    Hai Zou et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
  14. Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma
    Lovisa Farnebo et al, 2015, Oncotarget CrossRef
  15. Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines
    Shadab Shahriari et al, 2017, Cancer Biomarkers CrossRef
  16. Roles of Toll-Like Receptor 3 in Human Tumors
    Xin Zheng et al, 2021, Frontiers in Immunology CrossRef
  17. Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
    Fernando Torres Andón et al, 2022, Biomedicines CrossRef

  18. Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer


    Tatsuya Yoshida et al, 2020, Clinical and Experimental Gastroenterology CrossRef
  19. Toll‐like receptor 3 agonist poly I:C reinforces the potency of cytotoxic chemotherapy via the TLR3‐UNC93B1‐IFN‐β signaling axis in paclitaxel‐resistant colon cancer
    Jiaojiao Zhao et al, 2019, Journal of Cellular Physiology CrossRef
  20. Cleavable conjugation of CpG oligodeoxynucleotides onto microparticles for facile release and cytokine induction in macrophages
    Hyo-Eun Jang et al, 2017, Applied Biological Chemistry CrossRef
  21. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones
    Mahmud Angrini et al, 2020, Tumor Microenvironment CrossRef